Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
British Journal of Clinical Pharmacology|August 15, 2015
Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patientsKatalin Monostory, Katalin Tóth, Ádám Kiss, et al.
Pharmacological Reports : PR|July 9, 2020
End-stage renal disease reduces the expression of drug-metabolizing cytochrome P450sMáté Tamás Déri, Ádám Ferenc Kiss, Katalin Tóth, et al.
Archiv Der Pharmazie|November 19, 2016
Identification of 8-Hydroxyquinoline Derivatives Active Against Somatic V658F Mutant JAK1-Dependent CellsRóbert Kiss, Dávid Bajusz, Rebekah Baskin, et al.
Biochemical and Biophysical Research Communications|November 17, 2012
Simvastatin inhibits the core promoter of the TXNRD1 gene and lowers cellular TrxR activity in HepG2 cellsLena Ekström, Maria Johansson, Katalin Monostory, et al.
Journal of Separation Science|March 21, 2009
Shotgun proteomic analysis of the microsomal fraction of eukaryotic cells using a two-dimensional reversed-phase x ion-pair reversed-phase HPLC setupMartin Wörner, Katja Melchior, Nathanaël Delmotte, et al.
Personalized Medicine|May 18, 2018
Phenoconversion of CYP2C9 in epilepsy limits the predictive value of CYP2C9 genotype in optimizing valproate therapyKatalin Tóth, Tamás Bűdi, Ádám Kiss, et al.
Scientific Reports|December 5, 2020
Association of clozapine-related metabolic disturbances with CYP3A4 expression in patients with schizophreniaÁdám Menus, Ádám Kiss, Katalin Tóth, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 25, 2005
Biotransformation of deramciclane in primary hepatocytes of rat, mouse, rabbit, dog, and humanKatalin Monostory, Krisztina Kohalmy, Krisztina Ludányi, et al.
Chemico-Biological Interactions|April 23, 2013
Dehydroepiandrosterone post-transcriptionally modifies CYP1A2 induction involving androgen receptorAles Belic, Katalin Tóth, Radim Vrzal, et al.
British Journal of Clinical Pharmacology|December 12, 2007
Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolismLászló Kóbori, Krisztina Kõhalmy, Pálma Porrogi, et al.
Pageof 8